Table 1.
Characteristics of study participants
| Patients (n = 49) | ||
|---|---|---|
| Continuous variables | Mean (SD) | Median (IQR) |
| Age (years) | 74.04 (7.37) | 74 (11) |
| HbA1c (%) | 7.19 (1.01) | 6.9 (1.0) |
| eGFR (mL/min/1.73 m2) | 71.42 (15.91) | 72.70 (21.21) |
| BMI (kg/m2) | 24.58 (4.41) | 23.95 (3.97) |
| Glucose intake (g/day) | 190.67 (48.33) | 198.00 (65.90) |
| Peak CRP (mg/dL) | 7.14 (5.04) | 6.65 (7.74) |
| Peak ΔInsulin (U/day) | 7.61 (10.76) | 4 (8) |
| Categorical variables | n (%) |
|---|---|
| Male sex | 26 (53) |
| OHA use | 39 (80) |
No patient used glucagon‐like peptide‐1 receptor agonists. Δ, Differential value from the mean; BMI, body mass index; CRP, C‐reactive protein; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; IQR, interquartile range; OHA, oral hypoglycemic agent; SD, standard deviation.